John Boyce

Co-Founder, President & CEO, Chairman of the Board at BrickBio, Inc.

John Boyce is a seasoned entrepreneur and executive in the life sciences sector, currently serving as the Managing Director and Co-Founder of TigerGene LLC, a venture capital fund focused on early-stage life science technologies. Boyce co-founded and leads BrickBio and NanoMosaic, companies that specialize in innovative therapeutic conjugation and protein detection technologies, respectively. Previously, Boyce held leadership roles at Exosome Diagnostics, GnuBIO, and Delphi Bio Consulting, where significant value was created for investors. Additionally, Boyce contributes to academia as a Harvard Fellow, teaching innovation and entrepreneurship. Notable achievements include successful exits that yielded high returns on investment and the founding of the Consumer Genetics Conference, which highlighted advancements in direct-to-consumer genetic testing.

Links

Previous companies

Exosome Diagnostics logo